Pseudoprogression in boron neutron capture therapy for malignant gliomas and meningiomas
Open Access
- 1 August 2009
- journal article
- case report
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 11 (4) , 430-436
Abstract
Pseudoprogression has been recognized and widely accepted in the treatment of malignant gliomas, as transient increases in the volume of the enhancedKeywords
This publication has 30 references indexed in Scilit:
- Incidence of early pseudo‐progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomideCancer, 2008
- Reirradiation Tolerance of the Human BrainInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- BORON NEUTRON CAPTURE THERAPY FOR MALIGNANT TUMORS RELATED TO MENINGIOMASNeurosurgery, 2007
- Boron neutron capture therapy for recurrent malignant meningiomaJournal of Neurosurgery, 2006
- Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimagesJournal of Neurosurgery, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- MECHANISMS OF RADIATION INJURY TO THE CENTRAL NERVOUS SYSTEM: IMPLICATIONS FOR NEUROPROTECTIONMolecular Interventions, 2004
- Reversible neurotoxicity following hyperfractionated radiation therapy of brain stem gliomaMedical and Pediatric Oncology, 1991
- Synthesis and radiation dosimetry of 4-borono-2-[18F]fluoro-d,l-phenylalanine: A target compound for PET and boron neutron capture therapyInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1991
- Reversible Oedema and Necrosis after Irradiation of the Brain Diagnostic Procedures and Clinical ManifestationsActa Oncologica, 1990